155 related articles for article (PubMed ID: 17541422)
1. RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research.
Chang H
Cancer Gene Ther; 2007 Aug; 14(8):677-85. PubMed ID: 17541422
[TBL] [Abstract][Full Text] [Related]
2. RNA interference: implications for cancer treatment.
Masiero M; Nardo G; Indraccolo S; Favaro E
Mol Aspects Med; 2007 Feb; 28(1):143-66. PubMed ID: 17307250
[TBL] [Abstract][Full Text] [Related]
3. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
4. Prospects of RNA interference therapy for cancer.
Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
[TBL] [Abstract][Full Text] [Related]
5. RNA interference: a practical approach.
Duxbury MS; Whang EE
J Surg Res; 2004 Apr; 117(2):339-44. PubMed ID: 15047140
[TBL] [Abstract][Full Text] [Related]
6. RNA interference technologies and their use in cancer research.
Gaither A; Iourgenko V
Curr Opin Oncol; 2007 Jan; 19(1):50-4. PubMed ID: 17133112
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy developments for pancreatic cancer.
Bhattacharyya M; Lemoine NR
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
[TBL] [Abstract][Full Text] [Related]
8. [Effect of RNAi-mediated STAT3 gene inhibition on metastasis of human pancreatic cancer cells].
Gao Z; Huang C; Qiu ZJ; Jiang T; Zhu L; Cao J; Zhang F; Huang KJ
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1010-3. PubMed ID: 19035205
[TBL] [Abstract][Full Text] [Related]
9. RNAi therapy for neurodegenerative diseases.
Boudreau RL; Davidson BL
Curr Top Dev Biol; 2006; 75():73-92. PubMed ID: 16984810
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
[TBL] [Abstract][Full Text] [Related]
11. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation.
Taniguchi K; Momiyama N; Ueda M; Matsuyama R; Mori R; Fujii Y; Ichikawa Y; Endo I; Togo S; Shimada H
Anticancer Res; 2008; 28(3A):1559-63. PubMed ID: 18630511
[TBL] [Abstract][Full Text] [Related]
12. RNA interference as a novel and powerful tool in immunopharmacological research.
Kong Y; Ruan L; Ma L; Cui Y; Wang JM; Le Y
Int Immunopharmacol; 2007 Apr; 7(4):417-26. PubMed ID: 17321464
[TBL] [Abstract][Full Text] [Related]
13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
Pan Q; Liu B; Liu J; Cai R; Liu X; Qian C
Acta Oncol; 2008; 47(1):135-44. PubMed ID: 17934893
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.
Gonzalez-Alegre P
Pharmacol Ther; 2007 Apr; 114(1):34-55. PubMed ID: 17316816
[TBL] [Abstract][Full Text] [Related]
17. RNA interference screening for the discovery of oncology targets.
Quon K; Kassner PD
Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets.
Folini M; Pennati M; Zaffaroni N
Methods Mol Biol; 2009; 487():303-30. PubMed ID: 19301654
[TBL] [Abstract][Full Text] [Related]
19. RNA interference: emerging diagnostics and therapeutics tool.
Shrey K; Suchit A; Nishant M; Vibha R
Biochem Biophys Res Commun; 2009 Aug; 386(2):273-7. PubMed ID: 19523438
[TBL] [Abstract][Full Text] [Related]
20. Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research.
Dasgupta R; Perrimon N
Oncogene; 2004 Nov; 23(51):8359-65. PubMed ID: 15517017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
